EDAP TMS SA (EDAP) has reported a 19.85 percent rise in profit for the quarter ended Mar. 31, 2017. The company has earned $1.80 million, or $0.06 a share in the quarter, compared with $1.50 million, or $0.06 a share for the same period last year.

Revenue during the quarter dropped 3.55 percent to $9.28 million from $9.63 million in the previous year period. Gross margin for the quarter contracted 824 basis points over the previous year period to 40.94 percent. Operating margin for the quarter stood at negative 4.84 percent as compared to a positive 8.39 percent for the previous year period.

Operating loss for the quarter was $0.45 million, compared with an operating income of $0.81 million in the previous year period.

"Our first quarter revenues remain in line with our revenues from first quarter 2016", said Marc Oczachowski, EDAP's chief executive officer. "We continue to expand our education efforts in the U.S. as demonstrated by our successful addition of more than 50 new urologists to our HIFU training program during the first quarter. As a result, momentum in the U.S. continues as evidenced by the significant growth of our pipeline of HIFU projects. Global HIFU treatment driven revenue continues to increase with 16.5% growth year over year, while our global UDS/Lithotripsy business grew 16.5% compared to the first quarter of 2016."